News-Papers
Testimonial
Video Gallery
Effect of Vitamin E as an Immunopotentiation Agent and Its Influence on Tumor Growth in Mice
Published on Wednesday, 11 April 2018
Effect of Vitamin E as an Immunopotentiation Agent and Its Influence on Tumor Growth in Mice
See also:
- The Di Bella Method (A Fixed Part - Alpha tocopheryl acetate/Vitamin E);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);
- The Di Bella Method (A Fixed Part - All-Trans Retinoic Acid, Analogues and/or Derivatives).
Search
Follow us...
Latest
- Molecular mechanisms of melatonin anticancer effects
- Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)
- Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer
- Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases
- Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study
- Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
- Melatonin as a modulator of apoptosis in B-Lymphoma Cells
- Somatostatin in oncology, the overlooked evidences
- Cancer and Vitamin E
- About melatonin - 1996
- Vitamin D and cancer
- All-trans-retinoic acid and cancer
- Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
- Melatonin, circadian rhythms and breast cancer
- Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts
- THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer